BenQ Medical Technology Corporation (TPEX:4116)
Taiwan
· Delayed Price · Currency is TWD 41.55
+0.15 (0.36%)
May 13, 2025, 1:02 PM CST
BenQ Medical Technology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 4,938 | 4,767 | 4,543 | 4,377 | 1,465 | 1,401 | Upgrade
|
| Revenue Growth (YoY) | 8.62% | 4.94% | 3.80% | 198.82% | 4.55% | 1.49% | Upgrade
|
| Cost of Revenue | 3,406 | 3,319 | 3,199 | 3,129 | 952.31 | 849.22 | Upgrade
|
| Gross Profit | 1,532 | 1,448 | 1,344 | 1,247 | 512.28 | 551.63 | Upgrade
|
| Selling, General & Admin | 1,150 | 1,079 | 947.17 | 855.13 | 423.58 | 409.99 | Upgrade
|
| Research & Development | 36.89 | 36.39 | 31.96 | 39.58 | 39.65 | 44.3 | Upgrade
|
| Other Operating Expenses | - | - | -1.53 | 0.73 | 0.81 | - | Upgrade
|
| Operating Expenses | 1,186 | 1,115 | 978.46 | 896.88 | 465.82 | 454.42 | Upgrade
|
| Operating Income | 346.01 | 333.02 | 365.44 | 350.26 | 46.46 | 97.21 | Upgrade
|
| Interest Expense | -37.47 | -34.22 | -27.94 | -17.83 | -3.91 | -4.02 | Upgrade
|
| Interest & Investment Income | 11.18 | 11.23 | 10.21 | 5.24 | 0.69 | 0.8 | Upgrade
|
| Earnings From Equity Investments | - | - | -57.38 | -125.05 | 1.79 | 4.15 | Upgrade
|
| Currency Exchange Gain (Loss) | 8.98 | 8.98 | -2.5 | 3.44 | -0.53 | -3.52 | Upgrade
|
| Other Non Operating Income (Expenses) | 11.42 | 10.91 | 17.15 | 14.28 | 16.56 | 10.4 | Upgrade
|
| EBT Excluding Unusual Items | 340.12 | 329.91 | 304.98 | 230.33 | 61.06 | 105.03 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 5.13 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.9 | -0.9 | -0.03 | 3.85 | 0.06 | 0.07 | Upgrade
|
| Other Unusual Items | 0.37 | 0.37 | 0.09 | 81.57 | 0.66 | 0.57 | Upgrade
|
| Pretax Income | 339.59 | 329.38 | 310.17 | 315.74 | 61.78 | 105.67 | Upgrade
|
| Income Tax Expense | 97.01 | 92.13 | 109.91 | 79.15 | 12.75 | 21.55 | Upgrade
|
| Earnings From Continuing Operations | 242.58 | 237.25 | 200.26 | 236.6 | 49.04 | 84.12 | Upgrade
|
| Minority Interest in Earnings | -138.17 | -132.42 | -85.68 | -56.35 | -20.2 | -22.07 | Upgrade
|
| Net Income | 104.41 | 104.83 | 114.58 | 180.24 | 28.84 | 62.05 | Upgrade
|
| Net Income to Common | 104.41 | 104.83 | 114.58 | 180.24 | 28.84 | 62.05 | Upgrade
|
| Net Income Growth | -8.94% | -8.51% | -36.43% | 524.98% | -53.52% | -17.71% | Upgrade
|
| Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 | 45 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 | 45 | Upgrade
|
| Shares Change (YoY) | 0.20% | 0.02% | -0.07% | 0.42% | -0.30% | -0.09% | Upgrade
|
| EPS (Basic) | 2.34 | 2.35 | 2.57 | 4.04 | 0.65 | 1.39 | Upgrade
|
| EPS (Diluted) | 2.33 | 2.34 | 2.56 | 4.02 | 0.65 | 1.39 | Upgrade
|
| EPS Growth | -9.01% | -8.59% | -36.32% | 521.20% | -53.44% | -17.26% | Upgrade
|
| Free Cash Flow | -35.32 | 52.14 | 308.88 | 405.95 | 91.09 | 115.07 | Upgrade
|
| Free Cash Flow Per Share | -0.79 | 1.16 | 6.89 | 9.05 | 2.04 | 2.57 | Upgrade
|
| Dividend Per Share | 1.650 | 1.650 | 2.000 | 2.100 | 0.500 | 1.000 | Upgrade
|
| Dividend Growth | -17.50% | -17.50% | -4.76% | 320.00% | -50.00% | -25.93% | Upgrade
|
| Gross Margin | 31.03% | 30.38% | 29.58% | 28.50% | 34.98% | 39.38% | Upgrade
|
| Operating Margin | 7.01% | 6.98% | 8.04% | 8.00% | 3.17% | 6.94% | Upgrade
|
| Profit Margin | 2.11% | 2.20% | 2.52% | 4.12% | 1.97% | 4.43% | Upgrade
|
| Free Cash Flow Margin | -0.71% | 1.09% | 6.80% | 9.28% | 6.22% | 8.21% | Upgrade
|
| EBITDA | 529.63 | 509.07 | 532.15 | 520.51 | 107.71 | 146.02 | Upgrade
|
| EBITDA Margin | 10.72% | 10.68% | 11.71% | 11.89% | 7.36% | 10.42% | Upgrade
|
| D&A For EBITDA | 183.62 | 176.05 | 166.72 | 170.24 | 61.25 | 48.81 | Upgrade
|
| EBIT | 346.01 | 333.02 | 365.44 | 350.26 | 46.46 | 97.21 | Upgrade
|
| EBIT Margin | 7.01% | 6.98% | 8.04% | 8.00% | 3.17% | 6.94% | Upgrade
|
| Effective Tax Rate | 28.57% | 27.97% | 35.43% | 25.07% | 20.63% | 20.39% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.